INTERNATIONAL PATENT: BLUE BEES THERAPEUTICS, COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES FILES APPLICATION FOR "IMMUNOMODULATORY FC-BASED FUSION PROTEIN AND USES THEREOF FOR THERAPY"

GENEVA, Oct. 13 -- BLUE BEES THERAPEUTICS (Pepiniere d'Entreprises Wipse Parc, Club Orsay Universite21 Rue Jean Rostand91400 ORSAY), COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (25 rue LeblancBat le Ponant75015 PARIS) filed a patent application (PCT/EP2025/059366) for "IMMUNOMODULATORY FC-BASED FUSION PROTEIN AND USES THEREOF FOR THERAPY" on Apr 04, 2025. With publication no. WO/2025/210269, the details related to the patent application was published on Oct 09, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LEONETTI, Michel (c/o BLUE BEES THERAPEUTICSPepiniere d'Entrepris...